Sono-photodynamic combination therapy: A review on sensitizers

Anticancer Research

Volumn 34, Issue 9, 2014, Pages 4657-4664

  Sadanala, Krishna Chaitanya ^a   Chaturvedi, Pankaj Kumar ^a   Seo, You Mi ^a   Kim, Jeung Mo ^a   Jo, Yong Sam ^a   Lee, Yang Koo ^b   Ahn, Woong Shick ^a  

^a WonKwang Digital University   (South Korea)

^b Dongsung Pharmaceutical Company   (South Korea)

Author keywords

Photodynamic therapy; Review; Sensitizer; Sono photodynamic therapy; Sonodynamic therapy

Indexed keywords

CHLORINE DERIVATIVE; CHLORINE E6; HEMATOPORPHYRIN DERIVATIVE; PHOTOLON; PHOTOSENSITIZING AGENT; SONOFLORA 1; UNCLASSIFIED DRUG;

BREAST; CANCER GROWTH; CANCER THERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERMETHOD COMPARISON; INTESTINE; LIGHT; OVARY CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKIN CANCER; SONODYNAMIC THERAPY; SOUND; SUPERFICIAL CANCER; THERAPY EFFECT; TUMOR CELL DESTRUCTION; ULTRASOUND THERAPY; ANIMAL; MULTIMODALITY CANCER THERAPY; NEOPLASM; PHOTOCHEMOTHERAPY; SENSITIZATION; SONO-PHOTODYNAMIC THERAPY;

PHOTODYNAMIC THERAPY; REVIEW; SENSITIZER; SONO-PHOTODYNAMIC THERAPY; SONODYNAMIC THERAPY;

ANIMALS; COMBINED MODALITY THERAPY; HUMANS; LIGHT; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SOUND; ULTRASONIC THERAPY;

EID: 84908681864     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Levitzki A and Klein S: Signal transduction therapy of cancer. Mol Aspects Med of medicine 31: 287-329, 2010.
2. Mohan C: Signal Transduction: A Short Overview of its Role in Health and Disease, Second edition. EMD Biosciences: 2010. San Diego, CA, United States.
3. Alberts B BD, Lewis J, Raff M, Roberts K and Watson J D: Transport from the Plasma Membrane via Endosomes: Endocytosis. Molecular Biology of the Cell Third edition.1994. Garland Publishing, New York and London.
4. Levitzki A: Signal-transduction therapy. A novel approach to disease management. Eur J Biochem 226: 1-13, 1994.
5. Klein S and Levitzki A: Targeted cancer therapy: promise and reality. Adv Cancer Res 97: 295-319, 2007.
6. Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, Giorgi C, Missiroli S, Poletti F, Rimessi A and Pinton P: Protein kinases and phosphatases in the control of cell fate. Enzyme Res 2011: 329098, 2011.
7. Augsten caCH M, Peña C and Östman A: A digest on the role of the tumor microenvironment in gastrointestinal Cancers. Cancer Microenviron 3: 167-176, 2010.
8. Pietras K, Rubin K, Sjoblom T, Buchdunger E, Sjoquist M, Heldin CH and Ostman A: Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 62: 5476-5484, 2002.
9. Clinical Considerations for Therapeutic Cancer Vaccines, Guidance for Industry: U.S. Department of Health and Human Services, October 2011, Rockville, MD, USA.
10. Arora A and Scholar EM: Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 315: 971-979, 2005.
11. Krohner KM and Spitak AF: Cancer nursing education in the community hospital: principles and practice. Oncol Nurs Forum 19: 783-786, 1992.
12. Postiglione I, Chiaviello A and Palumbo G: Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers 3: 2597-2629, 2011.
13. Jaracz S, Chen J, Kuznetsova LV and Ojima I: Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 13: 5043-5054, 2005.
14. Ocana A, Pandiella A, Siu LL and Tannock IF: Preclinical development of molecular-targeted agents for cancer. Nat Rev Clin Oncol 8: 200-209, 2011.
15. Dolmans DE, Fukumura D and Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387, 2003.
16. Wilson BC: Photodynamic therapy for cancer: principles. Can J Gastroenterol 16: 393-396, 2002.
17. Vrouenraets MB, Visser GW, Snow GB and van Dongen GA: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23: 505-522, 2003.
18. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998.
19. Gudgin Dickson EF, Goyan RL, and Pottier RH: New directions in photodynamic therapy. Cell Mol Biol 48: 939-954, 2002.
20. Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11: 349-363, 2004.
21. Abulafi AM and Williams NS: Photodynamic therapy for cancer. Br Med J 304: 589-590, 1992.
22. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC and Golab J: Photodynamic therapy of cancer: an update. CA Cancer J Clin 61: 250-281, 2011.
23. Berg H: Photodynamic tumour therapy and cancer multistep therapy. J Photochem Photobiol B, Biol 2: 404-406, 1988.
24. Berg K, Madslien K, Bommer JC, Oftebro R, Winkelman JW and Moan J: Light induced relocalization of sulfonated mesotetraphenylporphines in NHIK 3025 cells and effects of dose fractionation. Photochem and photobiol 53: 203-210, 1991.
25. Delaney TF and Glatstein E: Photodynamic therapy of cancer. Compr Ther 14: 43-55, 1988.
26. Musser DA, Wagner JM, Weber FJ and Datta-Gupta N: The binding of tumor localizing porphyrins to a fibrin matrix and their effects following photoirradiation. Res Commun Chem Pathol Pharmacol 28: 505-525, 1980.
27. Cunderlikova B, Gangeskar L and Moan J: Acid-base properties of chlorin e6: relation to cellular uptake. J Photochem Photobiol B, Biol 53: 81-90, 1999.
28. Zhao X, Li H and Lee RJ: Targeted drug delivery via folate receptors. Expet Opin Drug Deliv 5: 309-319, 2008.
29. Sheleg EAZ SV, Khodina TV, GA Kochubeev, YP Istomin, VN Chalov, IN Zhuravkin: Photodynamic therapy with chlorin e6 for skin metastases of melanoma. Photodermatol Photoimmunol Photomed 20: 21-26, 2004.
30. Yumita N and Umemura S: Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour. J phar pharmacol 56: 85-90, 2004.
31. Lovell JF, Liu TW, Chen J and Zheng G: Activatable photosensitizers for imaging and therapy. Chem Rev 110: 2839-2857, 2010.
32. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, and Hasan T: Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 110: 2795-2838, 2010.
33. Umemura S KK, Sasaki K, Yumita N, Umemura K, Nishigaki R: Recent advances in sonodynamic approach to cancer therapy. Ultrason Sonochem 3: S187-S191, 1996.
34. Kinoshita M and Hynynen K: Mechanism of porphyrin-induced sonodynamic effect: possible role of hyperthermia. Radiat Res 165: 299-306, 2006.
35. Huang D, Okada K, Komori C, Itoi E, Kawamura K and Suzuki T: Ultrastructure of sarcoma 180 cells after ultrasound irradiation in the presence of sparfloxacin. Anticancer Res 24: 1553-1559, 2004.
36. Apkarian VA: Chemistry. A pixellated window on chemistry in solids. Science 313: 1747-1748, 2006.
37. Yumita N, Han QS, Kitazumi I, and Umemura S: Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6. Cancer sci 99: 166-172, 2008.
38. Jensen JA: A model for the propagation and scattering of ultrasound in tissue. J Acoust Soc Am 89: 182-190, 1991.
39. Ziskin MC: Fundamental physics of ultrasound and its propagation in tissue. Radiographics: a review publication of the Radiological Society of North America, Inc 13: 705-709, 1993.
40. Kondo T and Kano E: Effect of free radicals induced by ultrasonic cavitation on cell killing. Int J Radiat Biol 54: 475-486, 1988.
41. Kondo T US and Tanabe K: Novel therapeutic applications of ultrasound: utilization of thermal and cavitational effects. Jpn J Hyperther Oncol 16: 203-216, 2000.
42. Loreto B FL and Kondo T: Biological effects of low intensity ultrasound: The mechanism involved, and its implications on therapy and on biosafety of ultrasound. J Radiat Res 45: 479-489, 2004.
43. Capella MA and Capella LS: A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J Biomed Sci 10: 361-366, 2003.
44. Kondo K, Miyoshi T, Takizawa H, Kenzaki K, Sakiyama S and Tangoku A: Photodynamic therapy for submucosal tumor of the central bronchus. The journal of medical investigation: J Med invest 52: 208-211, 2005.
45. Foroulis CN and Thorpe JA: Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. E Eur J Cardiothorac Surg 29: 30-34, 2006.
46. Umemura S, Yumita N and Nishigaki R: Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res: Gann 84: 582-588, 1993.
47. W. Wang JZ, Liu W, Bai L, Gai H, Ye L, Tan Y and Yang T: Treatment of unrecetable nodular hepatocellular carcinoma with high-intensity focused ultrasound combined transarterial oily chemoembolization: preliminary clinical outcomes. In: Second International Symposium on Therapeutic Ultrasound. Seatle, Washington, USA, pp. 11-12.
48. CB Jin FW, Wang ZB and Chen WZ: High intensity focused ultrasound therapy in combination with transcatheyer arterial chemoembolism for advanced hepatocellular carcinoma: a primary clinical study 2nd international Symposim on Therapeutic Ultrasound. In: Second International Symposim on Therapeutic Ultrasound. Seatle, Washington, USA, pp. 44-45.
49. Lejbkowicz F and Salzberg S: Distinct sensitivity of normal and malignant cells to ultrasound in vitro. Environ Health Persp 105(Suppl 6): 1575-1578, 1997.
50. Lejbkowicz F, Zwiran M, and Salzberg S: The response of normal and malignant cells to ultrasound in vitro. Ultrasound Med Biol 19: 75-82, 1993.
51. Jin ZH, Miyoshi N, Ishiguro K, Umemura S, Kawabata K, Yumita N, Sakata I, Takaoka K, Udagawa T, Nakajima S, Tajiri H, Ueda K, Fukuda M, and Kumakiri M: Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Dermatol 27: 294-306, 2000.
52. Julian N, Richard JF and Thomas JL: Activated cancer therapy using light and ultrasound - a case series of sonodynamic photodynamic therapy in 115 patients over a 4 year period. Curr Drug Ther: 179-193, 2009.
53. Julian NK and Richard JF: Outcome measures following sono-dynamic photodynamic therapy. Curr Drug Ther: 12-16, 2011.
54. Su X, Li L and Wang P: Research progress of the anti-tumor effect of sonodynamic and photodynamic therapy. J Biomed Eng 29: 583-587, 2012.
55. Moghissi K and Dixon K: Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years's experience. Technol Cancer Res T 2: 319-326, 2003.
56. McCaughan CR B, Fowley C, Nomikou N, McHale AP, McCarron PA and Callan JF: Enhanced ROS production and cell death through comibined photo-and-sono-activation of conventional photosensitizing drugs. Bioorg Med Chem Lett 21: 5750-5752, 2011.
57. Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer cell 10: 175-176, 2006.
58. Huang Z: A review of progress in clinical photodynamic therapy. Technol Cancer Res T 4: 283-293, 2005.
59. Yamaguchi S, Kobayashi H, Narita T, Kanehira K, Sonezaki S, Kudo N, Kubota Y, Terasaka S and Houkin K: Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy. Ultrason Sonochem 18: 1197-1204, 2011.
60. Dougherty TJ: Photodynamic therapy. Photochem Photobiol 58: 895-900, 1993.
61. Bellnier DA, Ho YK, Pandey RK, Missert JR and Dougherty TJ: Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50: 221-228, 1989.
62. Umemura S, Yumita N, Nishigaki R and Umemura K: Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res Gann 81: 962-966, 1990.
63. Palumbo G: Photodynamic therapy and cancer: a brief sightseeing tour. Expert Opin Drug Deliv 4: 131-148, 2007.
64. Roberts WG and Hasan T: Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Res 53: 153-157, 1993.
65. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res: Gann 80: 219-222, 1989.
66. Kostenich GA, Zhuravkin IN and Zhavrid EA: Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors. J photochem photobiol B, Biol 22: 211-217, 1994.
67. Kasuya K, Shimazu M, Suzuki M, Kuroiwa Y, Usuda J, Itoi T, Tsuchida A and Aoki T: Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy. J Hepatobiliary Pancr sci 17: 313-321, 2010.
68. Ali-Seyed M, Bhuvaneswari R, Soo KC and Olivo M: Photolon - photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol 39: 821-831, 2011.
69. Kessel D and Poretz RD: Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME). Photochem Photobiol 71: 94-96, 2000.
70. Chen B, Zheng R, Liu D, Li B, Lin J and Zhang W: The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer. Ultrason Sonochem 20: 667-673, 2013.
71. Li Q, Wang X, Wang P, Zhang K, Wang H, Feng X and Liu Q: Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells. Cancer Biother Radio 29: 42-52, 2014.
72. Lukyanov AN and Torchilin VP: Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56: 1273-1289, 2004.
73. Kaneda Y, Tsutsumi Y, Yoshioka Y, Kamada H, Yamamoto Y, Kodaira H, Tsunoda S, Okamoto T, Mukai Y, Shibata H, Nakagawa S and Mayumi T: The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials 25: 3259-3266, 2004.
74. Isakau HA, Parkhats MV, Knyukshto VN, Dzhagarov BM, Petrov EP and Petrov PT: Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizer-polymer interaction in vitro. J photochem Photobiol B Biol 92: 165-174, 2008.
75. Shliakhtsin SV, Trukhachova TV, Isakau HA and Istomin YP: Pharmacokinetics and biodistribution of Photolon (Fotolon) in intact and tumor-bearing rats. Photodiagnosis Photodyn Ther 6: 97-104, 2009.
76. Calzavara-Pinton PG, Venturini M and Sala R: Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology. J Eur Acad Dermatol Venereol 21: 293-302, 2007.
77. Tserkovsky DA, Alexandrova EN and Istomin YP: Photolon enhancement of ultrasound cytotoxicity. Exper Oncol 33: 107-109, 2011.
78. Tserkovsky DA, Alexandrova EN, Chalau VN and Istomin YP: Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model. Exper Oncol 34: 332-335, 2012.
79. Squamous cell cancer responds to SPDT therapy, January 5, 2012. PRNewswire, Sarasota, florida, USA.
80. Lewis TJ: Toxicity and cytopathogenic properties toward human melanoma cells of activated cancer therapeutics in zebra fish. Integr Cancer Ther 9: 84-92, 2010.
81. Wang X, Zhang W, Xu Z, Luo Y, Mitchell D and Moss RW: Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of three cases. Integr Cancer Ther 8: 283-287, 2009.
82. Huang Z, Moseley H and Bown S: Rationale of combined PDT and SDT modalities for treating cancer patients in terminal stage: the proper use of photosensitizer. Integr Cancer Ther 9: 317-319; discussion 320-311, 2010.
83. Wang P, Wang XB, Liu QH, Tang W and Li T: Enhancement of ultrasonically induced cytotoxic effect by hematoporphyrin in vitro. Chemotherapy 54: 364-371, 2008.
84. Xiaohuai W, Lewis TJ and Mitchell D: The tumoricidal effect of sonodynamic therapy (SDT) on S-180 sarcoma in mice. Integr Cancer Ther 7: 96-102, 2008.
85. Shibaguchi H, Tsuru H, Kuroki M and Kuroki M: Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res 31: 2425-2429, 2011.
86. Prakash Rai SM: Development and Applications of Photo-triggered Theranostic Agents. Adv Drug Deliv Rev 2010: 1094-1124, 2010.
87. Zheng Huang HX and Yang K: Chen: Photodynamic therapy for treatment of solid tumors - potential and technical challenges. Technol Cancer Res T 7: 309-320, 2008.
88. Schmidt MH, Bajic DM, Reichert KW, 2nd, Martin TS, Meyer GA and Whelan HT: Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery 38: 552-556; discussion 556-557, 1996.
89. Brancaleon L and Moseley H: Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17: 173-186, 2002.
90. Yu T: A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11: 95-103, 2004.
91. Suzuki N, Okada K, Chida S, Komori C, Shimada Y and Suzuki T: Antitumor effect of acridine orange under ultrasonic irradiation in vitro. Anticancer Res 27: 4179-4184, 2007.
92. Ashush H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, Zipori D and Rosenschein U: Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 60: 1014-1020, 2000.
93. Robinson TC and Lele PP: An analysis of lesion development in the brain and in plastics by high-intensity focused ultrasound at low-megahertz frequencies. J Acoust Soc Am 51: 1333-1351, 1972.
94. Carstensen EL, Kelly P, Church CC, Brayman AA, Child SZ, Raeman CH and Schery L: Lysis of erythrocytes by exposure to CW ultrasound. Ultrasound Med Biol 19: 147-165, 1993.
95. Honda H, Zhao QL and Kondo T: Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 28: 673-682, 2002.
96. Feril LB, Jr., Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S and Nakamura S: Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29: 331-337, 2003.
97. Miller MW, Miller DL and Brayman AA: A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 22: 1131-1154, 1996.
98. Feigl T, Volklein B, Iro H, Ell C and Schneider T: Biophysical effects of high-energy pulsed ultrasound on human cells. Ultrasound Med Biol 22: 1267-1275, 1996.
99. Fry FJ, Goss SA and Patrick JT: Transkull focal lesions in cat brain produced by ultrasound. J Neurosurg 54: 659-663, 1981.
100. Lele PP: Advanced ultrasonic techniques for local tumor hyperthermia. Radiol Clin North Am 27: 559-575, 1989.
101. Lynn JG: Histology of cerebral lesions produced by focused ultrasound. Am J Pathol 20: 637-694, 1944.